Side effects, quality of life, and treatment adherence in melanoma patients undergoing systemic therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s00761-023-01370-5.pdf
Reference34 articles.
1. Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022) Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment. ESMO Open 7(5):100588. https://doi.org/10.1016/j.esmoop.2022.100588
2. Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A (2019) Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7(1):106. https://doi.org/10.1186/s40425-019-0585-1
3. Atkinson TM, Hay JL, Young Kim S, Schofield E, Postow MA, Momtaz P, Warner AB, Shoushtari AN, Callahan MK, Wolchok JD, Li Y, Chapman PB (2023) Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy. Oncologist. https://doi.org/10.1093/oncolo/oyac266
4. Beisel C, Poretta T, Sheppard VB, Hurtado-de Mendoza A, Sipsma H, Fuqua E, Stwalley B, Salvatore A, Yang M (2022) Adherence to adjuvant therapy in patients with resected melanoma: an application of the theory of planned behavior. Adv Ther 39(9):4061–4075. https://doi.org/10.1007/s12325-022-02221-2
5. Chernyshov PV, Lallas A, Tomas-Aragones L, Arenbergerova M, Samimi M, Manolache L, Svensson A, Marron SE, Sampogna F, Spillekom-vanKoulil S, Bewley A, Forsea AM, Jemec GB, Szepietowski JC, Augustin M, Finlay AY (2019) Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer. J Eur Acad Dermatol Venereol 33(5):816–827. https://doi.org/10.1111/jdv.15487
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3